Control of response to estramustine phosphate therapy through cytology and DNA analysis of cell nuclei in prospective study.
D001707:Biopsy, Needle; D002467:Cell Nucleus / Q000032:analysis*; D004273:DNA, Neoplasm / Q000032:analysis*; D004341:Drug Evaluation; D004961:Estramustine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010783:Photometry; D011446:Prospective Studies; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000032:analysis / Q000188:drug therapy / Q000473:pathology; D013997:Time Factors
D004273:DNA, Neoplasm; D009588:Nitrogen Mustard Compounds; D004961:Estramustine